Financial Advantage’s Labcorp LH Stock Holding History

Financial Advantage’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-186	Closed	-$26K	–	122
2019 Q3	$26K	Buy	+186	New	+$27.1K	0.02%	107

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Advantage's LH Position: Q4 2019 in Review

Financial Advantage sold out of Labcorp (LH) in Q4 2019, closing a stake of 186 shares — an estimated $26K sold.

Financial Advantage first reported a position in LH in Q3 2019 and held it in 1 quarter. The position peaked at $26K in Q3 2019. 802 funds tracked by Wall St. Rank hold LH as of Q4 2019.

Financial Advantage reported no remaining Labcorp position as of Q4 2019 after selling out during the quarter.
Financial Advantage sold 186 Labcorp shares in Q4 2019, an estimated $26K.
Financial Advantage first reported a position in Labcorp in Q3 2019 and held it in 1 quarter.
Financial Advantage's Labcorp position peaked at $26K in Q3 2019.
802 funds tracked by Wall St. Rank held Labcorp as of Q4 2019.

Based on Financial Advantage's 13F filing for Q4 2019, filed 31 Jan 2020.